Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis.

Wolf P, Nghiem DX, Walterscheid JP, Byrne S, Matsumura Y, Matsumura Y, Bucana C, Ananthaswamy HN, Ullrich SE.

Am J Pathol. 2006 Sep;169(3):795-805.

2.

Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor.

Zhang Q, Mousdicas N, Yi Q, Al-Hassani M, Billings SD, Perkins SM, Howard KM, Ishii S, Shimizu T, Travers JB.

J Clin Invest. 2005 Oct;115(10):2855-61. Epub 2005 Sep 22.

3.
4.

Platelet-activating factor blockade inhibits the T-helper type 17 cell pathway and suppresses psoriasis-like skin disease in K5.hTGF-β1 transgenic mice.

Singh TP, Huettner B, Koefeler H, Mayer G, Bambach I, Wallbrecht K, Schön MP, Wolf P.

Am J Pathol. 2011 Feb;178(2):699-708. doi: 10.1016/j.ajpath.2010.10.008.

5.

Serotonin signalling is crucial in the induction of PUVA-induced systemic suppression of delayed-type hypersensitivity but not local apoptosis or inflammation of the skin.

Wolf P, Byrne SN, Limon-Flores AY, Hoefler G, Ullrich SE.

Exp Dermatol. 2016 Jul;25(7):537-43. doi: 10.1111/exd.12990. Epub 2016 Apr 18.

6.

Platelet activating factor receptor binding plays a critical role in jet fuel-induced immune suppression.

Ramos G, Kazimi N, Nghiem DX, Walterscheid JP, Ullrich SE.

Toxicol Appl Pharmacol. 2004 Mar 15;195(3):331-8.

PMID:
15020195
7.

Platelet-activating factor does not mediate UVB-induced local immune suppression.

Sahu RP, Yao Y, Konger RL, Travers JB.

Photochem Photobiol. 2012 Mar-Apr;88(2):490-3. doi: 10.1111/j.1751-1097.2011.01071.x. Epub 2012 Jan 31.

8.

Platelet activating factor/platelet activating factor receptor pathway as a potential therapeutic target in autoimmune diseases.

Edwards LJ, Constantinescu CS.

Inflamm Allergy Drug Targets. 2009 Jul;8(3):182-90. Review.

PMID:
19601878
9.

A platelet-activating factor (PAF) receptor deficiency exacerbates diet-induced obesity but PAF/PAF receptor signaling does not contribute to the development of obesity-induced chronic inflammation.

Yamaguchi M, Matsui M, Higa R, Yamazaki Y, Ikari A, Miyake M, Miwa M, Ishii S, Sugatani J, Shimizu T.

Biochem Pharmacol. 2015 Feb 15;93(4):482-95. doi: 10.1016/j.bcp.2014.12.022. Epub 2015 Jan 8.

PMID:
25577975
10.

Ultraviolet B radiation generates platelet-activating factor-like phospholipids underlying cutaneous damage.

Marathe GK, Johnson C, Billings SD, Southall MD, Pei Y, Spandau D, Murphy RC, Zimmerman GA, McIntyre TM, Travers JB.

J Biol Chem. 2005 Oct 21;280(42):35448-57. Epub 2005 Aug 22.

11.

Psoralen with ultraviolet A-induced apoptosis of cutaneous lymphoma cell lines is augmented by type I interferons via the JAK1-STAT1 pathway.

Liszewski W, Naym DG, Biskup E, Gniadecki R.

Photodermatol Photoimmunol Photomed. 2017 May;33(3):164-171. doi: 10.1111/phpp.12302. Epub 2017 Apr 17.

PMID:
28196286
12.

Platelets in the immune response: Revisiting platelet-activating factor in anaphylaxis.

Gill P, Jindal NL, Jagdis A, Vadas P.

J Allergy Clin Immunol. 2015 Jun;135(6):1424-32. doi: 10.1016/j.jaci.2015.04.019.

PMID:
26051949
13.

Psoralen and Ultraviolet A Light Treatment Directly Affects Phosphatidylinositol 3-Kinase Signal Transduction by Altering Plasma Membrane Packing.

Van Aelst B, Devloo R, Zachée P, t'Kindt R, Sandra K, Vandekerckhove P, Compernolle V, Feys HB.

J Biol Chem. 2016 Nov 18;291(47):24364-24376. Epub 2016 Sep 29.

14.

Photo-activated psoralen binds the ErbB2 catalytic kinase domain, blocking ErbB2 signaling and triggering tumor cell apoptosis.

Xia W, Gooden D, Liu L, Zhao S, Soderblom EJ, Toone EJ, Beyer WF Jr, Walder H, Spector NL.

PLoS One. 2014 Feb 14;9(2):e88983. doi: 10.1371/journal.pone.0088983. eCollection 2014.

15.
16.

Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis.

Doppalapudi S, Jain A, Chopra DK, Khan W.

Eur J Pharm Sci. 2017 Jan 1;96:515-529. doi: 10.1016/j.ejps.2016.10.025. Epub 2016 Oct 21.

PMID:
27777066
17.

Expression of the platelet-activating factor receptor results in enhanced ultraviolet B radiation-induced apoptosis in a human epidermal cell line.

Barber LA, Spandau DF, Rathman SC, Murphy RC, Johnson CA, Kelley SW, Hurwitz SA, Travers JB.

J Biol Chem. 1998 Jul 24;273(30):18891-7.

18.

Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks.

Sivanesan SP, Gattu S, Hong J, Chavez-Frazier A, Bandow GD, Malick F, Kricorian G, Koo J.

J Am Acad Dermatol. 2009 Nov;61(5):793-8. doi: 10.1016/j.jaad.2009.04.053. Epub 2009 Sep 18.

PMID:
19766350
19.

Platelet activating factor-induced apoptosis is inhibited by ectopic expression of the platelet activating factor G-protein coupled receptor.

Brewer C, Bonin F, Bullock P, Nault MC, Morin J, Imbeault S, Shen TY, Franks DJ, Bennett SA.

J Neurochem. 2002 Sep;82(6):1502-11.

20.

Dermal exposure to jet fuel suppresses delayed-type hypersensitivity: a critical role for aromatic hydrocarbons.

Ramos G, Limon-Flores AY, Ullrich SE.

Toxicol Sci. 2007 Dec;100(2):415-22. Epub 2007 Sep 22.

PMID:
17890764

Supplemental Content

Support Center